Please login to the form below

Not currently logged in
Email:
Password:

Matthew Speers appointed as new chief executive of PAGB

UCB's former UK and Ireland general manager will take up post next year

PAGB Matthews SpeersMatthew Speers will next year take the helm at the Proprietary Association of Great Britian (PAGB), the UK trade association for over-the-counter medicines and food supplements.

Speers was most recently general manager for the UK and Ireland at UCB Pharma, a role he held for five years until April this year.

Prior to this he spent nearly two years as a regional general manager at UCB and before that was CEO of a biotech, a management consultant and served at GlaxoSmithKline in a variety of roles.

He will join the PAGB on January 6, 2014, and take up the CEO post on February 1, 2014, when current chief executive, Sheila Kelly, steps down.

Speers said: “I am hugely excited to be appointed to the role of chief executive at PAGB. The Association has been very successful in helping to drive change in the regulatory environment and in creating the very positive climate for self-care that we enjoy in the UK.

“I am looking forward to working with our member companies and the stakeholders we partner with to build on that so the consumer healthcare sector can develop and thrive.”

25th November 2013

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...